[Diabetes mellitus during interferon therapy]

MeSH terms

• Adult
• Anti-HIV Agents / therapeutic use
• Antiviral Agents / administration & dosage
• Antiviral Agents / adverse effects*
• Antiviral Agents / therapeutic use
• Diabetes Mellitus, Type 2 / chemically induced*
• Diabetes Mellitus, Type 2 / epidemiology
• Diabetic Ketoacidosis / chemically induced
• Drug Therapy, Combination
• HIV Infections / complications
• HIV Infections / drug therapy
• Hepatitis C, Chronic / complications
• Hepatitis C, Chronic / drug therapy*
• Humans
• Incidence
• Interferon alpha-2
• Interferon-alpha / administration & dosage
• Interferon-alpha / adverse effects*
• Interferon-alpha / therapeutic use
• Male
• Polyethylene Glycols / administration & dosage
• Polyethylene Glycols / adverse effects*
• Polyethylene Glycols / therapeutic use
• Recombinant Proteins
• Ribavirin / administration & dosage
• Ribavirin / therapeutic use